Modern Chinese Medicine Group delays circular despatch to 30 June 2026, seeks Listing Rules waiver

Bulletin Express04-30 20:04

Modern Chinese Medicine Group Co., Ltd. has announced a second postponement in sending out its shareholder circular for the proposed major transaction involving the acquisition of sale shares.

The company had previously targeted 30 April 2026 for despatch, as disclosed in its 9 February 2026 delay announcement. Additional time is now required to finalise the pro-forma financial information of the enlarged group. As a result, management expects the circular to be distributed on or before 30 June 2026.

To accommodate the revised timeline, the company has applied to The Stock Exchange of Hong Kong Limited for a waiver from strict compliance with Rule 14.41(a) of the Listing Rules. The stock exchange has not yet granted the waiver; the company will issue further updates when available.

The board currently comprises three executive directors—Sun Xinlei, Zhang Hongli and Jia Yanru—and three independent non-executive directors—Liu Ling, Leung Tsz Wing and Wong Chi Kin.

The announcement was authorised for release by executive director Zhang Hongli on 30 April 2026 in Hong Kong.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1143240829?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-30 20:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1143240829","market":"hk","top_or_hot":-1,"title":"Modern Chinese Medicine Group delays circular despatch to 30 June 2026, seeks Listing Rules waiver","media":"Bulletin Express","content":"<p>Modern Chinese Medicine Group Co., Ltd. has announced a second postponement in sending out its shareholder circular for the proposed major transaction involving the acquisition of sale shares.</p>\n<p>The company had previously targeted 30 April 2026 for despatch, as disclosed in its 9 February 2026 delay announcement. Additional time is now required to finalise the pro-forma financial information of the enlarged group. As a result, management expects the circular to be distributed on or before 30 June 2026.</p>\n<p>To accommodate the revised timeline, the company has applied to The Stock Exchange of Hong Kong Limited for a waiver from strict compliance with Rule 14.41(a) of the Listing Rules. The stock exchange has not yet granted the waiver; the company will issue further updates when available.</p>\n<p>The board currently comprises three executive directors—Sun Xinlei, Zhang Hongli and Jia Yanru—and three independent non-executive directors—Liu Ling, Leung Tsz Wing and Wong Chi Kin.</p>\n<p>The announcement was authorised for release by executive director Zhang Hongli on 30 April 2026 in Hong Kong.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Modern Chinese Medicine Group delays circular despatch to 30 June 2026, seeks Listing Rules waiver</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModern Chinese Medicine Group delays circular despatch to 30 June 2026, seeks Listing Rules waiver\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-30 20:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Modern Chinese Medicine Group Co., Ltd. has announced a second postponement in sending out its shareholder circular for the proposed major transaction involving the acquisition of sale shares.</p>\n<p>The company had previously targeted 30 April 2026 for despatch, as disclosed in its 9 February 2026 delay announcement. Additional time is now required to finalise the pro-forma financial information of the enlarged group. As a result, management expects the circular to be distributed on or before 30 June 2026.</p>\n<p>To accommodate the revised timeline, the company has applied to The Stock Exchange of Hong Kong Limited for a waiver from strict compliance with Rule 14.41(a) of the Listing Rules. The stock exchange has not yet granted the waiver; the company will issue further updates when available.</p>\n<p>The board currently comprises three executive directors—Sun Xinlei, Zhang Hongli and Jia Yanru—and three independent non-executive directors—Liu Ling, Leung Tsz Wing and Wong Chi Kin.</p>\n<p>The announcement was authorised for release by executive director Zhang Hongli on 30 April 2026 in Hong Kong.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01643","symbol_name":"现代中药集团","start_time":0,"source_url":"","article_id":"1143240829","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1143240829","pubTimestamp":1777550642,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Modern Chinese Medicine Group Co., Ltd. has announced a second postponement in sending out its shareholder circular for the proposed major transaction involving the acquisition of sale shares. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01643":"现代中药集团"},"translate_title":"现代中药集团延迟寄发通函至2026年6月30日寻求上市规则豁免","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01643":1},"content_text":"Modern Chinese Medicine Group Co., Ltd. has announced a second postponement in sending out its shareholder circular for the proposed major transaction involving the acquisition of sale shares.\nThe company had previously targeted 30 April 2026 for despatch, as disclosed in its 9 February 2026 delay announcement. Additional time is now required to finalise the pro-forma financial information of the enlarged group. As a result, management expects the circular to be distributed on or before 30 June 2026.\nTo accommodate the revised timeline, the company has applied to The Stock Exchange of Hong Kong Limited for a waiver from strict compliance with Rule 14.41(a) of the Listing Rules. The stock exchange has not yet granted the waiver; the company will issue further updates when available.\nThe board currently comprises three executive directors—Sun Xinlei, Zhang Hongli and Jia Yanru—and three independent non-executive directors—Liu Ling, Leung Tsz Wing and Wong Chi Kin.\nThe announcement was authorised for release by executive director Zhang Hongli on 30 April 2026 in Hong Kong.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1143240829","isCrawlerRequest":true}